John R. Ussher retweeted
Our LinkedIn page is now live!
Give us a follow to stay up to date with all things SHVM 2025 and beyond #longlivemetabolism #SHVM
👇
linkedin.com/company/shvm
John R. Ussher retweeted
Stay tuned for further updates as we near the 22nd Annual SHVM meeting: Shedding Light on Emerging Metabolic Targets in Cardiovascular Diseases 🫀
Abstract submission 17 March 2025
Early bird registration 18 April 2025
Registration and payment deadline 15 May 2025
John R. Ussher retweeted
I'm looking to hire a fully funded PhD student this year. If you are interested in investigating mitochondrial bioenergetics in diverse tissues please reach out.
John R. Ussher retweeted
Excited to share my work with @DanielJDrucker on the role for GIPR agonism alone and with GLP-1R agonism (@tirzepatide_ ) in the regulation of gut inflammation, and providing new insights on the localization of the GIP receptor in the gut. See paper here: insight.jci.org/articles/vie…
John R. Ussher retweeted
Finally the latest baby of the Quebec PAH and vascular biology research group is out 😎. Congrats Dr Grobs @Grobs4
@3CPRCouncil @PVRI @ATS_PC @PullamsettiL @Savai_Lab @facmedUL
science.org/doi/10.1126/scit…
John R. Ussher retweeted
Using multiple techniques the authors affirm that Gfral expression is overwhelmingly restricted to the brainstem in healthy mice @MolMetab @cusm_muhc @seeleyrj sciencedirect.com/science/ar…
John R. Ussher retweeted
Check our last review in the special issue of Essays in Biochemistry on AMPK and AMPK-related kinase👉AMPK and O-GlcNAcylation: interplay in cardiac pathologies and heart failure portlandpress.com/essaysbioc… @ISHR_ES @escardio @GRRC_SFCardio
John R. Ussher retweeted
The SUMMIT trial Tirzepatide for #HeartFailure with Preserved Ejection Fraction in PPL with #Obesity A lower risk of a composite of death from cardiovascular causes or worsening heart failure nejm.org/doi/full/10.1056/NE…
John R. Ussher retweeted
On #WorldDiabetesDay2024 congratulations to Professor Erin Mulvihill @HeartInstitute @OttawaU @uOttawaBMI @CIHR_IRSC this years receipient of the early career investigator award from @DiabetesCanada Felicitations! #diabetes
John R. Ussher retweeted
Semaglutide Reduces Cardiomyocyte Size and Cardiac Mass in Lean and Ob... sciencedirect.com/science/ar…
John R. Ussher retweeted
Reporting with pride: (1) our star Jessie Axsom is now Dr.! (2) her paper is out @Cell_Metabolism: unbelievably comprehensive quantification of fuel fluxes in #exercise mice - lots of surprises. #MoTrPAC: take note. w/Rabinowitz lab. Free link 50days: authors.elsevier.com/a/1jxL7…
John R. Ussher retweeted
See our new review on #AMPK and O-GlcNAcylation: interplay in cardiac pathologies and heart failure portlandpress.com/essaysbioc…
#heartfailure #Essays @ISHR_ES @GRRC_SFCardio @escardio
John R. Ussher retweeted
🚨New Paper Alert🚨
Our new #microbiome research, co-led with @LiatShenhav, published today in @CellCellPress!
We show that #breastfeeding "paces" gut & nasal microbiome development to prevent #asthma in the @CHILDSTUDY.
#Tweetorial 🧵
cell.com/cell/fulltext/S0092…
John R. Ussher retweeted
New data from the Shulman lab provide insights into the mechanisms by which inhibition of ceramide synthesis, by either myriocin or Des1 ASO treatment, protects rodents from lipid-induced hepatic #insulin resistance cell.com/cell-reports/fullte… @CellReports
John R. Ussher retweeted
An exhaustive review from @mferdaoussi on insulin secretion.
“Metabolic and Molecular Amplification of Insulin Secretion”
pubmed.ncbi.nlm.nih.gov/3928…
John R. Ussher retweeted
Thank you from the organizers and board members for a great meeting. See you next year in Bordeaux! 👏
John R. Ussher retweeted
Hot off the press:
Muscle Matters: the Impact of Medically Induced Weight Loss on Skeletal Muscle.
thelancet.com/journals/landi…
@TheLancetEndo
Pérdida de masa muscular con medicamentos para la pérdida de peso.
Perda da massa muscular com medicamentos para perda de peso.
“Regulatory agencies should provide more comprehensive guidelines for monitoring and evaluating body composition changes, mandate well-designed body composition studies, and enhance post-market surveillance."
"GLP-1 receptor agonists have revolutionized obesity treatment and demonstrated substantial benefits... However, the potential impact of muscle mass loss as now observed remains a concern. These highly effective medications should be used strategically, in a multimodal approach to improve the quality of weight loss by optimizing body composition."
Thanks to my dear colleagues/friends: @mackinprof @Kryz5559 and Steven Heymsfield for their partnership!
@UofAALES @AlbertaDiabetes @UofAResearch
Figure: Dual role of muscle as both a structural and metabolic organ.
John R. Ussher retweeted
Some thoughts on:
Intermittent fasting immunity and metabolism
cell.com/trends/endocrinolog…
John R. Ussher retweeted
Online now! Mitochondrial transplants to treat mitochondrial dysfunction dlvr.it/TCjPm9
John R. Ussher retweeted
Two great opportunities in Toronto! apply.interfolio.com/152420




























